EMD-62593

Single-particle
2.63 Å
EMD-62593
3D View Gallery
Deposition: 05/12/2024
Map released: 03/12/2025
Last modified: 17/06/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62593

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9kvg summary report (pdf.gz) Map-9kvg FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

A Cryo_EM structure of 5_HT1A complex with 5-Meo-DMT

EMD-62593

Single-particle
2.63 Å
EMD-62593
3D View Gallery
Deposition: 05/12/2024
Map released: 03/12/2025
Last modified: 17/06/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: 5-HT1A complex with 5-MEO-DMT
Fitted models: 9kvg

Deposition Authors: Yuan Q, Li S
Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT 1A Receptor for Therapeutic Potential in Depression and Anxiety.
Li SJ, Yuan QN, Wu WY, Chen ZH, Chen D, Shan H, Chu QY, Hu W, Wu K, Liu T, Zhu YY, Hou L, Zhou J, Duan J, Duan JA, Xu HE, Ma HY
(2025) Res , 8 , 0987 - 0987
PUBMED: 41446874
DOI: doi:10.34133/research.0987
ISSN: 2639-5274